{
    "2020-12-16": [
        [
            {
                "time": "2020-12-16",
                "original_text": "U.S. hospital demand for Lilly, Regeneron COVID-19 antibody drugs 'disappointing'",
                "features": {
                    "keywords": [
                        "hospital",
                        "demand",
                        "Lilly",
                        "Regeneron",
                        "COVID-19",
                        "antibody",
                        "drugs",
                        "disappointing"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2020-12-16",
                "original_text": "SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Prevail Therapeutics Inc. Buyout",
                "features": {
                    "keywords": [
                        "SHAREHOLDER",
                        "ALERT",
                        "Rigrodsky",
                        "Long",
                        "Prevail",
                        "Therapeutics",
                        "Investigation",
                        "Buyout"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-12-16",
                "original_text": "Top Analyst Reports for Mastercard, Eli Lilly & Citigroup",
                "features": {
                    "keywords": [
                        "Analyst",
                        "Reports",
                        "Mastercard",
                        "Eli",
                        "Lilly",
                        "Citigroup"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-16",
                "original_text": "PREVAIL THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of PRVL and Encourages Investors to Contact the Firm",
                "features": {
                    "keywords": [
                        "PREVAIL",
                        "THERAPEUTICS",
                        "Bragar",
                        "Eagel",
                        "Squire",
                        "Sale",
                        "PRVL",
                        "Investors"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-12-16",
                "original_text": "Lilly (LLY) to Acquire Prevail Therapeutics for Gene Therapies",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Acquire",
                        "Prevail",
                        "Therapeutics",
                        "Gene",
                        "Therapies"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-16",
                "original_text": "Company News for Dec 16, 2020",
                "features": {
                    "keywords": [
                        "Company",
                        "News",
                        "Dec",
                        "16",
                        "2020"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2020-12-16",
                "original_text": "Lilly (LLY) Stock Up on Raised 2020 View, Upbeat 2021 Guidance",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Stock",
                        "Up",
                        "Raised",
                        "2020",
                        "View",
                        "Upbeat",
                        "2021",
                        "Guidance"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}